1. Practical application of population health and wellbeing approaches in the new policy context Professor Chris Bentley HINSTAssociatesHINSTAssociates

2. Messages from the Past

3. Ronald Labonte Well being and Health Physiological risks High blood pressure High cholesterol Stress hormones Anxiety/depression Behavioural risks Smoking Poor diet Lack of activity Substance abuse Psycho-social risks: Isolation Lack of social support Poor social networks Low self-esteem High self-blame Low perceived power Loss of meaning/purpose of life Risk conditions – e.g.: Poverty Low social status Unemployment Dangerous environments Discrimination Steep power heirarchy Gaps/weaknesses in services and support

4. 2005201020152020 Health Inequalities Different Gestation Times for Interventions A B C For example intervening to reduce risk of mortality in people with established disease such as CVD, cancer, diabetes For example intervening through lifestyle and behavioural change such as stopping smoking, reducing alcohol related harm and weight management to reduce mortality in the medium term For example intervening to modify the social determinants of health such as worklessness, poor housing, poverty and poor education attainment to impact on mortality in the long term

5. Partnership, Vision and Strategy, Leadership and Engagement Population Level Interventions Intervention Through Communities Intervention Through Services Systematic and scaled interventions through services Systematic community engagement Service engagement with the community Producing Percentage Change at Population LevelC. Bentley 2007

6. Achieving Percentage Change in Population Outcomes Programme characteristics will include being :- – Evidence based – concentrate on interventions where research findings and professional consensus are strongest – Outcomes orientated – with measurements locally relevant and locally owned – Systematically applied – not depending on exceptional circumstances and exceptional champions – Scaled up appropriately – “industrial scale” processes require different thinking to small “ bench experiments” – Appropriately resourced – refocus on core budgets and services rather than short bursts of project funding – Persistent – continue for the long haul, capitalising on, but not dependant on fads, fashion and policy priorities

7. T Hennell 2011

10. Health and Wellbeing Boards A shaky start?

11. A few early concerns Limited membership v. unmanageably large JSNAs very variable; not bottom-up and top-down; not driving the agenda Little knowledge or acknowledgement of Public Health Outcomes Framework Role not clear: strategic ‘forum’ (talking shop), or performance managing function Early HWS pink and fluffy; missing tangible stated outcomes with strategy for delivery Who is accountable for delivery of each priority to the Board Missing opportunities on ‘causes of the causes’

12. “ Social injustice is killing on a grand scale “ Sir Michael Marmot 2010 With thanks to Mike Grady University College London/ Marmot Review Team

13. Inequality in Early Cognitive Development of British Children in the 1970 Cohort, 22 months to 10 years High Q at 22m Low Q at 22m Source: Feinstein, L. (2003) ‘Inequality in the Early Cognitive Development of British Children in the 1970 Cohort’, Economica (70) 277, 73-97 High SES Low SES

14. Per cent achieving 5+ A* - C grades inc Maths and English at GCSE by IDACI decile of pupil residence: England 2007 % achieving 5+ A*-C GCSEs inc Maths and English Income Deprivation Affecting Children Index (IDACI) Least deprived Source: DCFS 2009 Most deprived

15. Clinical Commissioning Groups Inherent Schizophrenia?

16. A few early concerns Commissioner v Provider v Collaborative Partner Unequal pressures Leaders (hard-bitten experience v fresh faced enthusiast) Corporate memory v re-inventing wheels (flat tyres) Holistic overview v PPPs (personal perspective priorities) Transition (empowering possibilities) v Real World (reality/austerity bites) Variable mix of support/advice/guidance (CSS; NHS CBA; PH/PHE; Commercial sector) Little previous engagement with population perspective

17. Primary Care Direct Action HWBB JSNA HWBS Commissioning Primary Care Commissioned Service Primary Care Contribution to Health Improvement CCG contribution NHS Commissioning Board

18. 18 What is our ambition? What realistic but testing target are we aiming for? Can this be stated in terms that are easily understood and ‘owned’ by local stakeholders? In particular can it be pinned down to numbers? What are the main contributory factors responsible for the current adverse situation? What interventions could contribute substantially to these sort of numbers? Can they be delivered with sufficient system, scale and sustainability Can a realistic business case be developed to demonstrate appropriate return on investment? Outline

19. Case Study 1 Oldham CCG 19

20. 20 Setting Ambitions: Best in Peer Group (Males) Male All Age All Cause Mortality (AAACM) Rates by GP Consortia, 2007-09 * Peer group = Former Spearhead PCTs in ‘Centres with Industry’ ONS area classification Oldham South Birmingham

21. 21 Estimating the scale of the challenge (Males) Oldham Male AAACM rate 2001-2009, forecast and trajectory to 2013-15 ambition Equivalent to 417 (13%) fewer male deaths in 2013-15 270 fewer deaths in 2013-15 expected based on current trend

22. 22 Estimating the scale of the challenge : Summary 2007-09 AAACM (rate) 2013-15 ambition (rate) 2007-09 deaths (number) 2013-15 ambition (number) Required reduction (number) Expected reduction (number) Additional reduction Required Males833.6721.231002683417270147 Females597.7497.834102774636297339 Persons--651054571053567486 Reductions in mortality numbers necessary to meet 2013-15 targets

23. 23 Identifying ‘excess’ mortality by age group Number of excess deaths by age group in Oldham compared to England average, 2006-08 Source: Derived from London Public Health Observatory Health Inequalities Intervention Tool data

24. 24 Identifying ‘excess’ mortality by cause Number of excess deaths in Oldham by cause, gender and broad age group compared to England average, 2006-08 Source: Derived from NCHOD standardised mortality ratios (SMR) and mortality numbers by age and cause. Excess mortality = ‘observed’ minus ‘expected’ deaths Males Females

25. Gap in male life expectancy in Barnsley by disease

26. 26 Potential impact of evidence-based interventions on reducing mortality numbers NNT = Number Needed to Treat to postpone one death

27. 27 Aim: Deliver a short-term plan to place the PCT on a target AAACM trajectory for males The Plan: Focus on six evidence based interventions: 1.Full implementation of evidence based treatments for patients with CVD who are currently untreated 2.Full implementation of evidence based treatments for patients with CVD who are currently partially treated 3.Finding and treating undiagnosed hypertensives 4.Moving patients on Atrial Fibrillation registers from aspirin to warfarin 5.Statins to address CVD risk among COPD patients. 6.Reducing blood sugar in diabetic patients Expected Outcomes Improved management of primary and secondary prevention of CVD Postponement of up to 257 deaths from CVD if the interventions are fully implemented, although this would depend on pace of incremental delivery Achieving 38% of full implementation of all interventions would deliver the AAACM target although again this depends on pace of incremental delivery Using the model: a worked example (1) Source: Rochdale PCT AAACM Recovery Plan, Nov 2010

28. 28 Using the model: a worked example (3) Intervention: Statins to address CVD risk among patients with mild or moderate COPD Evidence Base: Observational studies show CVD is the leading cause of mortality among patients with mild and moderate COPD, yet CVD risk is often untreated among this patient group Treatment population: Aim to increase coverage from 26% to 66% of all COPD patients. (Current treatment coverage of 26% estimated from local audit of COPD registers plus estimate of undiagnosed COPD from APHO prevalence estimate.) Equates to an additional 2,450 COPD patients on a statin Outcomes: Estimated 55 deaths prevented (consistent with model which shows effect of additional 40% COPD patients on a statin) Costs: Recurrent costs of £95,000 (includes finding additional patients)

29. Case Study 2 Atypical situation – Blackpool PCT 29

30. 30 Setting Ambitions: Best in Peer Group (Males) Male All Age All Cause Mortality (AAACM) Rates by GP Consortia, 2008-10 *Peer group = PCTs in ‘Costal and Countryside ’ ONS area classification

31. 31 Setting Ambitions: Best in Peer Group (Males) Male All Age All Cause Mortality (AAACM) Rates by GP Consortia, 2008-10 *Peer group = Former Spearheads in the NHS North West Clinical Commissioning groups

32. 32 Estimating the scale of the challenge : Summary Reductions in mortality numbers necessary to meet 2014-16 targets

33. Excess Male Mortality (%) Blackpool vs. All Spearheads

34. Excess Female Mortality (%) Blackpool vs. All Spearheads

35. Gap in male life expectancy in Blackpool by disease

36. 36 Potential impact of evidence-based interventions on reducing mortality numbers NNT = Number Needed to Treat to postpone one death

37. Proportionate Need for Levels of ARH Service (not to scale) Tier 1 Tier 2 Tier 3 Tier 4 er Tier 1 Tier 2 Tier 4 Blackpool Tier 3 Average Borough

38. Case Study 3 Good average health with pockets of deprivation Kent CC 38

39. All age, all cause mortality rates, 3-year averages, Kent & Medway

40. Slope Index for Medway (Males)

42. Swale: Circulatory disease mortality by ward

43. Swale: Causes of excess mortality, worst quintile compared to rest

44. (Dis-)Integrated Commissioning for Population Health

45. Primary Care Direct Action HWB JSNA HWBS Commissioning Primary Care Commissioned Service Primary Care Contribution to Health Improvement CCG contribution NHS Commissioning Board

46. Commissioning Services to Achieve Best Population Outcomes Population Focus Optimal Population Outcome 13.Networks,leadership and coordination 1.Known Intervention Efficacy 6.Known Population Needs 12. Balanced Service Portfolio 11.Adequate Service Volumes Challenge to Providers 10. Supported self- management 5. Engaging the public 9. Responsive Services 4. Accessibility 7. Expressed Demand 2. Local Service Effectiveness 8. Equitable Resourcing 3.Cost Effectiveness C Bentley 2007

47. Improving Male Life Expectancy in Birmingham

48. 48 Identifying Primary Care performance to outcomes QOF registered prevalence and CHD Mortality(<75) in Oldham (MSOAs)

49. 49 10.2 m 19.9 m 2.6 m 17.1 m High RiskHave LTCAware of LTC Eligible for treatment Optimal treatment Compliant with treatment 5.7m 2.6m 2.3m 1.3m 1m 2.8m 1.8m 0.4m Not known 0.9m 0.48m 0.21m 0.1m 0.08m 2.9m 0.9m 0.52m 0.26m 0.14m CHF COPD 10.2 m 19.9 m High RiskHave LTCAware of LTC Eligible for treatment Compliant with treatment CHD Diabetes NOTE: Figures are for UK. Taken from Harrison W, Marshall T, Singh D & Tennant R “The effectiveness of healthcare systems in the UK – scoping study”; Department of Public Health & Epidemiology and HSMC University of Birmingham, July 2006. Disease management provided according to evidence- based protocols e.g. NSFs or NICE guidance

50. Quality of delivery

51. Wakefield

52. 52 Identifying the untreated patients (GP practice) CHD: Expected vs QOF Registered Prevalence (Percentage) A quarter of patients with a history of CHD are estimated undiagnosed (untreated)

53. 53 Identifying the untreated patients (GP practice) WAKEFIELD PCT

54. ALW – ‘thousands’ missing dementia diagnosis 54